Curetis' IPO

Curetis raised a round of funding on November 11, 2015. Investors include Public.

Curetis (AMS:CURE) is a molecular diagnostics company which focuses on the development and commercialization of reliable, fast, and cost-effective products for diagnosing severe infectious diseases. T…

Articles about Curetis' IPO: